CJN Article: "Israel, Canada Unite In Fight Against Prostate Cancer"

Bookmark and Share

NEW: A photo gallery of the event and attendees is now online on Macleans.ca.
Click here to view their page on "Hebrew University On The Hill".

CJN header - May 13

Israel, Canada unite in fight against prostrate cancerOTTAWA - Prostate Cancer Canada (PCC) and the Jerusalem-based Institute for Medical Research Israel-Canada (IMRIC) signed a partnership agreement last week, joining forces to battle prostate cancer, the most common cancer affecting Canadian men. They plan to work together in fundraising, education and research.

IMRIC, which is part of the Hebrew University of Jerusalem, is involved in international research collaborations on medical problems ranging from diabetes to HIV/AIDS.

Cedar, Lindenberg, ShiellAlmost 400 people – among them members of Parliament, senators and six cabinet ministers – attended the May 5 reception hosted by Canadian Friends of the Hebrew University (CFHU) and the Canada-Israel Interparliamentary Group in association with the Canadian Jewish Political Affairs Committee in celebration of Canadian-Israeli partnerships. CFHU has raised $20 million of a total $50-million commitment for IMRIC and its collaborative research.

“Canadian researchers have tremendous expertise and are doing groundbreaking work in prostate cancer research,” Steve Jones, president and CEO of PCC, said in a news release. “We’re excited to develop this relationship with IMRIC that will allow us to work together at home and internationally, so that we can improve diagnosis, treatment, and eventually find a cure for men, wherever they live.”

One in six Canadian men is diagnosed with prostate cancer, according to the release from CFHU.

CFHU national director Rami Kleinmann told The CJN, “We felt our duty should be not only as fund provider, but as a catalyst for advancing the scientific relationship between Canada and Israel.”

IMRIC has almost half a dozen major partnerships with Canadian researchers, he said. Among them is a partnership with the University of British Columbia and the Rick Hansen Foundation in the area of spinal cord injuries, and a cancer-related epigenetics project with McGill University.

Initiatives planned in conjunction with the new partnership include a countrywide speaker series to raise awareness about prostate cancer, Kleinmann said.

Parliament group photo

Follow us:

Visit our facebook page.TwitterInstagram

CFHU is dedicated to supporting IMRIC through direct funding and by developing key collaborative medical research partnerships between Canada
and Israel.


Get Involved!

Sign Up